Australian Super Pty LTD Abb Vie Inc. Transaction History

Australian Super Pty LTD

  • $19.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024
BUY
$154.79 - $180.76 $109,436 - $127,797
707 Added 8.45%
9,078 $1.56 Million
Q1 2024

Apr 26, 2024
SELL
$159.82 - $182.1 $131 Million - $149 Million
-820,290 Reduced 98.99%
8,371 $1.52 Million
Q4 2023

Jan 16, 2024
BUY
$137.6 - $154.97 $113 Million - $127 Million
819,251 Added 8706.17%
828,661 $128 Million
Q3 2023

Oct 27, 2023
BUY
$133.59 - $154.65 $1.26 Million - $1.46 Million
9,410 New
9,410 $1.4 Million

Others Institutions Holding ABBV

# of Institutions
3,863
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $299B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Australian Super Pty LTD Portfolio

Follow Australian Super Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email